Singapoo - Kiingereza - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - betamethasone dipropionate 0.643mg eqv betamethasone (micronized); calcipotriol monohydrate 52.2 mcg/g eqv calcipotriol - gel - 0.5 mg/g - betamethasone dipropionate 0.643mg eqv betamethasone (micronized) 0.5 mg/g; calcipotriol monohydrate 52.2 mcg/g eqv calcipotriol 0.05 mg/g

Singapoo - Kiingereza - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - betamethasone valerate eqv betamethasone; fusidic acid - cream - 1 mg/g - betamethasone valerate eqv betamethasone 1 mg/g; fusidic acid 20 mg/g

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - bleomycin sulfate, quantity: 15000 iu - injection, powder for - excipient ingredients: sodium hydroxide; hydrochloric acid - palliation and treatment adjuvant to surgery and radiation therapy of the following neoplasms: squamous cell carcinoma of the skin, head and neck, and oesophagus (primary indication). squamous cell carcinoma of the larynx, penis and uterine cervix. squamous cell carcinoma of the bronchus (response infrequent). choriocarcinoma and embryonal cell carcinoma of the testis. advanced hodgkin's disease and other lymphomas. mycosis fungoides note. use of bleomycin after radiation therapy is less successful than use before radiation therapy. bleomycin is bone marrow sparing and may be used when other cytotoxic agents are contraindicated.

Kanada - Kiingereza - Health Canada

pfizer canada ulc - bleomycin (bleomycin sulfate) - powder for solution - 15unit - bleomycin (bleomycin sulfate) 15unit - antineoplastic agents

Kanada - Kiingereza - Health Canada

fresenius kabi canada ltd - bleomycin (bleomycin sulfate) - powder for solution - 15unit - bleomycin (bleomycin sulfate) 15unit - antineoplastic agents

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - bleomycin sulfate, quantity: 15000 iu - injection, powder for - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - palliation and treatment adjuvant to surgery and radiation therapy of the following neoplasms: = squamous cell carcinoma of the skin, head and neck, and oesophagus (primary indication). = squamous cell carcinoma of the larynx, penis and uterine cervix. = squamous cell carcinoma of the bronchus (response infrequent). = choriocarcinoma and embryonal cell carcinoma of the testis. = advanced hodgkin's disease and other lymphomas. = mycosis fungoides.,note. use of bleomycin after radiation therapy is less successful than use before radiation therapy. bleomycin is bone marrow sparing and may be used when other cytotoxic agents are contraindicated.